Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome

Prediction of response to percutaneous sclerotherapy in patients with venous malformations (VM) is currently not possible with baseline clinical or imaging characteristics. This prospective single-center study aimed to predict treatment outcome of percutaneous sclerotherapy as measured by quality of...

Full description

Bibliographic Details
Main Authors: Mirjam Gerwing, Philipp Schindler, Kristian Nikolaus Schneider, Benedikt Sundermann, Michael Köhler, Anna-Christina Stamm, Vanessa Franziska Schmidt, Sybille Perkowski, Niklas Deventer, Walter L. Heindel, Moritz Wildgruber, Max Masthoff
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/6/1430
_version_ 1797488248103108608
author Mirjam Gerwing
Philipp Schindler
Kristian Nikolaus Schneider
Benedikt Sundermann
Michael Köhler
Anna-Christina Stamm
Vanessa Franziska Schmidt
Sybille Perkowski
Niklas Deventer
Walter L. Heindel
Moritz Wildgruber
Max Masthoff
author_facet Mirjam Gerwing
Philipp Schindler
Kristian Nikolaus Schneider
Benedikt Sundermann
Michael Köhler
Anna-Christina Stamm
Vanessa Franziska Schmidt
Sybille Perkowski
Niklas Deventer
Walter L. Heindel
Moritz Wildgruber
Max Masthoff
author_sort Mirjam Gerwing
collection DOAJ
description Prediction of response to percutaneous sclerotherapy in patients with venous malformations (VM) is currently not possible with baseline clinical or imaging characteristics. This prospective single-center study aimed to predict treatment outcome of percutaneous sclerotherapy as measured by quality of life (QoL) by using radiomic analysis of diffusion-weighted (dw) magnetic resonance imaging (MRI) before and after first percutaneous sclerotherapy. In all patients (<i>n</i> = 16) pre-interventional (PRE-) and delta (DELTA-) radiomic features (RF) were extracted from dw-MRI before and after first percutaneous sclerotherapy with ethanol gel or polidocanol foam, while QoL was assessed using the Toronto Extremity Salvage Score (TESS) and the 36-Item Short Form Survey (SF-36) health questionnaire. For selecting features that allow differentiation of clinical response, a stepwise dimension reduction was performed. Logistic regression models were fitted and selected PRE-/DELTA-RF were tested for their predictive value. QoL improved significantly after percutaneous sclerotherapy. While no common baseline patient characteristics were able to predict response to percutaneous sclerotherapy, the radiomics signature of VMs (independent PRE/DELTA-RF) revealed high potential for the prediction of clinical response after percutaneous sclerotherapy. This proof-of-concept study provides first evidence on the potential predictive value of (delta) radiomic analysis from diffusion-weighted MRI for Quality-of-Life outcome after percutaneous sclerotherapy in patients with venous malformations.
first_indexed 2024-03-10T00:00:25Z
format Article
id doaj.art-6f0f30db577749d0b2bf26205a5925ab
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T00:00:25Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-6f0f30db577749d0b2bf26205a5925ab2023-11-23T16:18:02ZengMDPI AGDiagnostics2075-44182022-06-01126143010.3390/diagnostics12061430Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical OutcomeMirjam Gerwing0Philipp Schindler1Kristian Nikolaus Schneider2Benedikt Sundermann3Michael Köhler4Anna-Christina Stamm5Vanessa Franziska Schmidt6Sybille Perkowski7Niklas Deventer8Walter L. Heindel9Moritz Wildgruber10Max Masthoff11Clinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyClinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyDepartment of Orthopedics and Tumor Orthopedics, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyClinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyClinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyClinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyDepartment of Radiology, University Hospital, LMU Munich, 80336 Munich, GermanyClinic for Pediatric and Neonatal Surgery, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyDepartment of Orthopedics and Tumor Orthopedics, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyClinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyClinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyClinic for Radiology, University of Muenster and University Hospital of Muenster, 48149 Muenster, GermanyPrediction of response to percutaneous sclerotherapy in patients with venous malformations (VM) is currently not possible with baseline clinical or imaging characteristics. This prospective single-center study aimed to predict treatment outcome of percutaneous sclerotherapy as measured by quality of life (QoL) by using radiomic analysis of diffusion-weighted (dw) magnetic resonance imaging (MRI) before and after first percutaneous sclerotherapy. In all patients (<i>n</i> = 16) pre-interventional (PRE-) and delta (DELTA-) radiomic features (RF) were extracted from dw-MRI before and after first percutaneous sclerotherapy with ethanol gel or polidocanol foam, while QoL was assessed using the Toronto Extremity Salvage Score (TESS) and the 36-Item Short Form Survey (SF-36) health questionnaire. For selecting features that allow differentiation of clinical response, a stepwise dimension reduction was performed. Logistic regression models were fitted and selected PRE-/DELTA-RF were tested for their predictive value. QoL improved significantly after percutaneous sclerotherapy. While no common baseline patient characteristics were able to predict response to percutaneous sclerotherapy, the radiomics signature of VMs (independent PRE/DELTA-RF) revealed high potential for the prediction of clinical response after percutaneous sclerotherapy. This proof-of-concept study provides first evidence on the potential predictive value of (delta) radiomic analysis from diffusion-weighted MRI for Quality-of-Life outcome after percutaneous sclerotherapy in patients with venous malformations.https://www.mdpi.com/2075-4418/12/6/1430venous malformationslow-flow vascular malformationsradiomicspercutaneous sclerotherapyquality of life
spellingShingle Mirjam Gerwing
Philipp Schindler
Kristian Nikolaus Schneider
Benedikt Sundermann
Michael Köhler
Anna-Christina Stamm
Vanessa Franziska Schmidt
Sybille Perkowski
Niklas Deventer
Walter L. Heindel
Moritz Wildgruber
Max Masthoff
Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome
Diagnostics
venous malformation
slow-flow vascular malformations
radiomics
percutaneous sclerotherapy
quality of life
title Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome
title_full Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome
title_fullStr Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome
title_full_unstemmed Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome
title_short Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome
title_sort diffusion weighted imaging prior to percutaneous sclerotherapy of venous malformations proof of concept study for prediction of clinical outcome
topic venous malformation
slow-flow vascular malformations
radiomics
percutaneous sclerotherapy
quality of life
url https://www.mdpi.com/2075-4418/12/6/1430
work_keys_str_mv AT mirjamgerwing diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT philippschindler diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT kristiannikolausschneider diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT benediktsundermann diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT michaelkohler diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT annachristinastamm diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT vanessafranziskaschmidt diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT sybilleperkowski diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT niklasdeventer diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT walterlheindel diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT moritzwildgruber diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome
AT maxmasthoff diffusionweightedimagingpriortopercutaneoussclerotherapyofvenousmalformationsproofofconceptstudyforpredictionofclinicaloutcome